Hap Trading, LLC Catalyst Pharmaceuticals, Inc. Call Options Transaction History

Hap Trading, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$12.25 - $19.5 $156,800 - $249,600	12,800 New	12,800 $34,000
Q2 2022 Aug 12, 2022	SELL	$6.23 - $8.57 $66,661 - $91,699	-10,700 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$5.31 - $8.31 $33,453 - $52,353	-6,300 Reduced 37.06%	10,700 $12,000
Q4 2021 Feb 14, 2022	BUY	$5.21 - $7.45 $10,941 - $15,645	2,100 Added 14.09%	17,000 $11,000
Q3 2021 Nov 10, 2021	BUY	$4.85 - $6.04 $1,455 - $1,812	300 Added 2.05%	14,900 $4,000
Q2 2021 Aug 11, 2021	SELL	$4.29 - $6.05 $9,867 - $13,915	-2,300 Reduced 13.61%	14,600 $3,000
Q1 2021 May 14, 2021	BUY	$3.45 - $4.69 $4,485 - $6,097	1,300 Added 8.33%	16,900 $5,000
Q4 2020 Feb 16, 2021	BUY	$2.97 - $3.83 $2,079 - $2,681	700 Added 4.7%	15,600 $3,000
Q3 2020 Nov 13, 2020	BUY	$2.97 - $5.08 $44,253 - $75,692	14,900 New	14,900 $3,000

328

94.2M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.35B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.